diaDexus , Inc.


349 Oyster Point BlvdSouth San FranciscoCalifornia94080United States View Map


$18.1 Million



SIC Codes:

2834, 8731

NAICS Codes:

325412, 541710


(650) 246-6400


(650) 264-6499


Diadexus, based in South San Francisco, California, is a diagnostics company developing and commercializing products that aid in the prediction of cardiac disease risk, providing healthcare providers with actionable information for managing patients. The Company pioneered the testing of Lp-PLA2, a marker of vascular-specific inflammation that provides new information, over and above traditional risk factors measured in a lipid panel, and has over a decade of peer-reviewed literature validating its utility. Diadexus' products, The PLAC® Test ELISA Kit, first cleared by the FDA in 2003, and The PLAC® Test for Lp-PLA2 Activity, cleared in December 2014, are the only two FDA-cleared tests to measure Lp-PLA2. The Company also has a pipeline of biomarkers for heart failure, proADM, proET-1 and proANP, with each providing distinct, additive information for healthcare providers over currently available markers. Diadexus also provides services to pharmaceutical partners to address the need to incorporate biomarkers in clinical development.

Read More


Recently Updated profiles at this company

President and Chief Executive Officer

Browse ZoomInfo’s Directories